| View HTML | View PDF | |
|---|---|---|
Section XII | ||
| 12.1a | Waiting List Patient Characteristics at End of Year Lung Waiting List Active Waitlist Patients, 1997 to 2006 |  (42 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Diagnosis | ||
| Gender | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Previous Transplant Same Organ | ||
| Time on Waiting List | ||
| 12.1b | Waiting List Patient Characteristics at End of Year Lung Waiting List Active and Inactive Patient Comparison, 2002 to 2006 | (37 k) |
| Age | ||
| Diagnosis | ||
| Gender | ||
| Race | ||
| Time on Waiting List | ||
| 12.2 | Time to Transplant, 1997 to 2006 New Lung Waiting List Registrations | (54 k) |
| Blood Type | ||
| Age | ||
| Gender | ||
| All Patient Types | ||
| Previous Transplant Any Organ | ||
| Race | ||
| Residency | ||
| 12.3 | Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2006 Lung Waiting List | (49 k) |
| Age | ||
| Blood Type | ||
| Diagnosis | ||
| Gender | ||
| Race | ||
| 12.4a | Transplant Recipient Characteristics, 1997 to 2006 Recipients of Deceased Donor Lungs | (46 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| Procedure Type | ||
| 12.4b | Transplant Recipient Characteristics, 1997 to 2006 Recipients of Living Donor Lungs | (45 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Donor Relation | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Payment Source | ||
| Procedure Type | ||
| 12.5 | Incidence of Transplant, 1997 to 2006 Lung Transplants per 1 Million Population | (29 k) |
| 12.6a | Immunosuppression Use for Induction, 1997 to 2006 Recipients with Lung Transplants | (29 k) |
| 12.6b | Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006 Recipients with Lung Transplants | (31 k) |
| 12.6c | Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006 Recipients with Lung Transplants | (29 k) |
| 12.6d | Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1997 to 2006 Recipients with Lung Transplants | (30 k) |
| 12.6e | Immunosuppression Use for Maintenance Prior to Discharge, 1997 to 2006 Recipients with Lung Transplants | (31 k) |
| 12.6f | Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1996 to 2005 Recipients with Lung Transplants | (31 k) |
| 12.6g | Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1996 to 2005 Recipients with Lung Transplants | (31 k) |
| 12.6h | Persistency of Discharge Regimen by Follow-up Period, 2001 to 2005 Recipients with Lung Transplants | (33 k) |
| 12.6i | Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1996 to 2005 Recipients with Lung Transplants | (30 k) |
| 12.7a | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Deceased Donor Lung Transplantation | (75 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Donor Age | ||
| Procedure Type | ||
| Age | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Any Organ | ||
| Diagnosis | ||
| 12.7b | Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1997 to 2005 Rates for Recipients during First Year after Living Donor Lung Transplantation | (63 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Donor Age | ||
| Procedure Type | ||
| Age | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Any Organ | ||
| Diagnosis | ||
| 12.8 | Adjusted Graft Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (36 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| 12.9a | Adjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Lung Transplants | (22 k) |
| 12.10a | Unadjusted Graft Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (43 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Previous Transplant Same Organ | ||
| Procedure Type | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| 12.10b | Unadjusted Graft Survival, Living Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (41 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Relation | ||
| Donor Age | ||
| Previous Transplant Same Organ | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| 12.11a | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Lung Transplants | (22 k) |
| 12.11b | Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Lung Transplants | (22 k) |
| 12.12 | Adjusted Patient Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (36 k) |
| Age | ||
| Gender | ||
| Race | ||
| Diagnosis | ||
| 12.13a | Adjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Lung Transplants | (22 k) |
| 12.14a | Unadjusted Patient Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (43 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Age | ||
| Procedure Type | ||
| Diagnosis | ||
| Cold Ischemic Time | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| 12.14b | Unadjusted Patient Survival, Living Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years | (40 k) |
| Age | ||
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Center Volume | ||
| Donor Relation | ||
| Donor Age | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| 12.15a | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Deceased Donor Lung Transplants | (22 k) |
| 12.15b | Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, 5 Years and 10 Years Living Donor Lung Transplants | (22 k) |
| 12.16 | Prevalence of People Living with a Functioning Transplant at End of Year Lung Recipients, 1997 to 2005 | (43 k) |
| Blood Type | ||
| Residency | ||
| Gender | ||
| Race | ||
| Age | ||
| Diagnosis | ||
| On Life Support at Tx | ||
| Hospitalized at Tx | ||
| Previous Transplant Same Organ | ||
| Previous Transplant Any Organ | ||
| Procedure Type | ||
| 12.17 | Transplants by State and Transplant Center, 1997 to 2006 Lung | (52 k) |